Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Studies such as EMPA-KIDNEY take a very large amount of collaborative effort from many hundreds of research staff around the world and can be costly to run. The study is sponsored by Boehringer Ingelheim which is providing the study pills. Boehringer Ingelheim has also provided a grant to the University of Oxford. Those running the study at the University of Oxford also receive support from the UK Medical Research Council and British Heart Foundation to run trials.